Institut de cancérologie de l'Ouest - Site Paul Papin

Angers 49100

0 studies enrolling now · 3 studies all time

What they study most

Estrogen Receptor Positive Breast Cancer, HER-2 Positive Breast Cancer, Pancreatic Ductal Carcinoma, Urothelial Cancer

Studies at this site

• Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer — Running, not enrolling
• A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) — Completed
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early